MLchartDataset catalogue

recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1

Term · Oncology and biomedicine · MLC-T-ONC-016417

A recombinant oncolytic adenovirus, controlled by synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Upon administration, the recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1 selectively targets, infects and replicates in tumor cells expressing the tumor-associated antigen (TAA) alpha-fetoprotein (AFP), thereby expressing GM-CSF and inducing tumor cell lysis. The lysis of cancer cells causes the release of cancer-specific antigens, and triggers systematic anti-tumor immune responses. In addition, GM-CSF attracts dendritic cells (DCs) and may further stimulate a cytotoxic T-cell response against tumor cells, which results in immune-mediated tumor cell death. The gene circuit contains a synthetic sensory switch that is under the control of a cancer-specific AFP promoter and multiple microRNA inputs. The gene circuits are triggered to activate viral replication and express hGM-CSF in AFP-expressing cancer cells, but not in normal cells.

Table 1. Record
IdentifierMLC-T-ONC-016417
FieldOncology and biomedicine
Synonymsoncolytic virotherapeutic SynOV1.1
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016417",
  "term": "recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1",
  "field": "Oncology and biomedicine",
  "definition": "A recombinant oncolytic adenovirus, controlled by synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Upon administration, the recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1 selectively targets, infects and replicates in tumor cells expressing the tumor-associated antigen (TAA) alpha-fetoprotein (AFP), thereby expressing GM-CSF and inducing tumor cell lysis. The lysis of cancer cells causes the release of cancer-specific antigens, and triggers systematic anti-tumor immune responses. In addition, GM-CSF attracts dendritic cells (DCs) and may further stimulate a cytotoxic T-cell response against tumor cells, which results in immune-mediated tumor cell death. The gene circuit contains a synthetic sensory switch that is under the control of a cancer-specific AFP promoter and multiple microRNA inputs. The gene circuits are triggered to activate viral replication and express hGM-CSF in AFP-expressing cancer cells, but not in normal cells.",
  "synonyms": [
    "oncolytic virotherapeutic SynOV1.1"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/recombinant-human-gm-csf-encoding-oncolytic-adenovirus-synov1-1/"
}

Record 14,160 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.